Liraglutide

Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

Saxenda: Underlying Mechanisms and Clinical Outcomes

Liraglutide Effect in Atrial Fibrillation

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Effects of GH and Lirglutide on AgRP

Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes

Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism

A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.

Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Anti-obesity Pharmacotherapy and Inflammation

HbA1c Variability in Type II Diabetes

Liraglutide in Adolescents With Type 1 Diabetes

Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)

Liraglutide and Peripheral Artery Disease